Dr. Tsinoremas will provide an overview of the University of Miami Institute for Data Science and Computing entitled “Big Data Approaches and Applications for Biomedical Data “, along with a brief description of its seven scientific programs and two technology platforms.

UM IDSC is a University-wide initiative focused on problem-solving approaches to societal problems where computing, informatics and team approaches play a significant and integral role. The Institute is involved in over 150+ University wide research projects at any given time, ranging from bioinformatics, big data in health care, drug discovery informatics, large mapping projects, climate change and environmental hazards, to architectural design, business analytics, digital humanities and visualization. A few example projects in Bioinformatics and Biomedical Informatics will be discussed in more detail as well as highlight of new innovative Big Data approaches to HealthCare.

October 13 @ 12:30 pm – 2:00 pm | CTRB Room 361, Clinical and Translational Science Building, 2004 Mowry Road, Gainesville, FL 32610   + Google Map

Bio

Dr. Nicholas Tsinoremas holds faculty appointments at the Miller School of Medicine and the College of Arts and Sciences at the University of Miami (UM) and is the Founding Director for the University of Miami Institute for Data Science and Computing. Dr. Tsinoremas is an international leader in computational genomics and bioinformatics, and brings over 25 years of academic and industrial experience to UM. He received his B.A. in Chemistry from the University of Athens, Greece, and his Ph.D. in Molecular Biology from the University of Leeds, UK. Before joining the University of Miami, he served as Senior Director of Informatics at The Scripps Research Institute-Florida. There, he recruited and managed the Informatics and IT groups for the newly formed Scripps Florida. As Director of Computational Genomics and Genomic Discovery at Rosetta/Merck where he directed the project that combined informatics and computational approaches with gene expression profiling and genetics to discover, prioritize, and define drug target genes. Prior to working for Merck/Rosetta, Tsinoremas was the Vice-President of Genomics at DoubleTwist Inc., where he determined the scientific direction of DoubleTwist’s bioinformatics applications and databases.